Muhammad Tukur Ibrahim

Muhammad Tukur Ibrahim

Auto-generated profile, based on publicly available information

Muhammad Tukur Ibrahim

Department of Chemistry, Faculty of Physical Sciences, Ahmadu Bello University, Zaria, Nigeria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2020 in European Journal of Chemistry
Verified
Journal Article
Open access
PDF file
MAMustapha Abdullahi
Mustapha Abdullahi
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
DADavid Arthur
David Arthur
ABAbdullahi Bello
Abdullahi Bello
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim
A virtual docking simulation study was performed on thirty-five newly discovered compounds of N-(2-phenoxy) ethyl imidazo[1,2-a] pyridine-3-carboxamide (IPA), to explore their theoretical binding energy and pose with the active sites of the Mycobacterium tuberculosis target (DNA gyrase). The chemical structures of the compounds were drawn correctly with ChemDraw Ultra software, and then geometrically optimized at DFT level of theory with Spartan 14 software package. Consequently, the docking analysis was carried out using Molegro Virtual Docker (MVD). Five complexes (Complex 5, 24, 25, 33 and 35) with high binding energy were selected to examine their binding pose with the active sites of the protein. The docking results suggested a good MolDock score (≥ -90 kcal/mol) and Protein-Ligand ANT System (PLANTS) score (≥ -60 kcal/mol) which depicted that the compounds can efficiently bind with the active sites of the target. However, compound 5 has the best binding pose with the MolDock score of -140.476 kcal/mol which formed three hydrogen bond interactions with the Gln 538, Ala 531, and Ala 533 amino acid residues. This research gives a firsthand theoretical knowledge to improve the binding efficiency of these compounds with the target.


12 March 2024 in Scientific African
Verified
Journal Article
Open access
SJSaudatu Chinade Jáafaru
Saudatu Chinade Jáafaru
AUAdamu Uzairu
Adamu Uzairu
MSMuhammed Sani Sallau
Muhammed Sani Sallau
GNGeorge Iloegbulam Ndukwe
George Iloegbulam Ndukwe
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim
VKVimal Kumar
Vimal Kumar

4 May 2025 in Turkish Computational and Theoretical Chemistry
Verified
Journal Article
Open access
PDF file
AMAliyu Wappah Mahmud
Aliyu Wappah Mahmud
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim
UAUsman Abdullahi
Usman Abdullahi
AMAhmad Mustapha
Ahmad Mustapha
Management and control of malaria remain challenging due to the continuous emergence of drug resistant and the adaptive nature of the mosquito vector. This necessitates the continuous discovery of potent antimalaria drugs. Lactate dehydrogenase from Plasmodium falciparum (PfLDH) is an essential catalyst for the parasite’s energy production. PfLDH is a significant target in the design and discovery of antimalarial drugs because its inhibition leads to the death of the parasite. In this work, fifteen 10-amidinobenzonaphthyridine molecules active against Chloroquine-sensitive and Chloroquine-resistant strains of P. falciparum were screened through molecular docking with the view to find lead inhibitor of PfLDH. The binding affinities of the compounds ranged from -5.5 to -7.8kcal/mol. The compound with the highest binding affinity was modified and nine novel 10-amidinobenzonaphthyridines were designed. The designed compounds have better binding affinity toward the target ranging from -7.8 to -8.8kcal/mol and four of which have better binding affinities than Pyronaridine, a 10-amidinobenzonaphthyridine antimalaria drug. Furthermore, ADME properties of the designed compounds were predicted in silico and their drug-likeness investigated using Lipinski’s rule of five and Veber’s rule of two. Based on these rules, compound D1, D2, D3, D4, D5 and D8 are potential oral drug candidates. Compound D2, D3 and D8 have good binding affinities and ADME properties therefore, can be developed into potent antimalaria targeting PfLDH. The results of this work can be used to develop active antimalaria drug capable of inhibiting PfLDH.

26 November 2025 in In Silico Pharmacology
Verified
Journal Article
Closed access
PDF file
JIJosiah Joseph Isah
Josiah Joseph Isah
AUAdamu Uzairu
Adamu Uzairu
SUSani Uba
Sani Uba
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim

27 December 2025 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Closed access
PDF file
JIJosiah Joseph Isah
Josiah Joseph Isah
AUAdamu Uzairu
Adamu Uzairu
SUSani Uba
Sani Uba
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim